Physician profile
Matthew Ritch
NPI 1619339082
$1,225.63
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $92.34 · 2021: $465 · 2022: $436 · 2023: $116 · 2024: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $232.36 | 2023-2024 | Xcopri |
| Teva Pharmaceuticals USA, INC. | $224.82 | 2020-2022 | |
| Glaxosmithkline, LLC. | $123.66 | 2021 | |
| Lilly USA, LLC | $115.21 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $103.28 | 2022 | |
| Biogen, INC. | $102.86 | 2020-2022 | |
| Abbvie INC. | $75.33 | 2022 | |
| Amgen INC. | $61.87 | 2021-2022 | |
| Emd Serono, INC. | $51.11 | 2021 | |
| Neurocrine Biosciences, INC. | $50.69 | 2022 | |
| Allergan, INC. | $30.74 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $30.24 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Ritch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.